Bionano Genomics, Inc. (BNGO)
0.8999
+0.01
(+1.68%)
USD |
NASDAQ |
Nov 20, 10:22
Bionano Genomics Free Cash Flow : -19.08M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -19.08M |
| June 30, 2026 | -20.48M |
| March 31, 2026 | -19.30M |
| December 31, 2025 | -16.34M |
| September 30, 2025 | -18.98M |
| June 30, 2025 | -26.37M |
| March 31, 2025 | -45.38M |
| December 31, 2024 | -70.77M |
| September 30, 2024 | -99.01M |
| June 30, 2024 | -112.07M |
| March 31, 2024 | -126.78M |
| December 31, 2023 | -131.39M |
| September 30, 2023 | -132.43M |
| June 30, 2023 | -135.82M |
| March 31, 2023 | -127.42M |
| December 31, 2022 | -128.12M |
| Date | Value |
|---|---|
| September 30, 2022 | -118.78M |
| June 30, 2022 | -109.26M |
| March 31, 2022 | -92.94M |
| December 31, 2021 | -73.39M |
| September 30, 2021 | -58.75M |
| June 30, 2021 | -49.46M |
| March 31, 2021 | -44.21M |
| December 31, 2020 | -38.31M |
| September 30, 2020 | -35.72M |
| June 30, 2020 | -31.94M |
| March 31, 2020 | -31.07M |
| December 31, 2019 | -29.59M |
| September 30, 2019 | -24.19M |
| June 30, 2019 | -23.23M |
| March 31, 2019 | -20.03M |
| December 31, 2018 | -20.28M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agilent Technologies, Inc. | 1.267B |
| Bio-Rad Laboratories, Inc. | 329.10M |
| Bruker Corp. | 244.70M |
| Danaher Corp. | 5.727B |
| Harvard Bioscience, Inc. | -3.603M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.524M |
| Cash from Investing (Quarterly) | 2.411M |
| Cash from Financing (Quarterly) | 2.737M |
| Free Cash Flow Per Share (Quarterly) | -0.3773 |
| Free Cash Flow to Equity (Quarterly) | -4.363M |
| Free Cash Flow to Firm (Quarterly) | -4.459M |
| Free Cash Flow Yield | -157.0% |